Deep top-down proteomics revealed significant proteoform-level differences between metastatic and nonmetastatic colorectal cancer cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Understanding cancer metastasis at the proteoform level is crucial for discovering previously unknown protein biomarkers for cancer diagnosis and drug development. We present the first top-down proteomics (TDP) study of a pair of isogenic human nonmetastatic and metastatic colorectal cancer (CRC) cell lines (SW480 and SW620). We identified 23,622 proteoforms of 2332 proteins from the two cell lines, representing nearly fivefold improvement in the number of proteoform identifications (IDs) compared to previous TDP datasets of human cancer cells. We revealed substantial differences between the SW480 and SW620 cell lines regarding proteoform and single amino acid variant (SAAV) profiles. Quantitative TDP unveiled differentially expressed proteoforms between the two cell lines, and the corresponding genes had diversified functions and were closely related to cancer. Our study represents a pivotal advance in TDP toward the characterization of human proteome in a proteoform-specific manner, which will transform basic and translational biomedical research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · cited 1×
“4F and 5 (E and F) were generated through the use of QIAGEN IPA (QIAGEN Inc.) ( 74 ).”
GENCODE: The reference human genome annotation for The ENCODE Project
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. (2012) · Genome Research · doi:10.1101/gr.135350.111 · Cited by 4,585
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
Proteoform: a single term describing protein complexity
The Consortium for Top Down Proteomics, Smith, L. M., & Kelleher, N. L. (2013) · Nature Methods · doi:10.1038/nmeth.2369 · Cited by 1,528 · cited 1×
“BUP usually provides limited information on the proteoforms, which represent all possible protein molecules derived from the same gene resulting from genetic variations, RNA alternative splicing, and protein posttranslational modifications (PTMs) ( 11 , 12 ).”
Proteogenomic characterization of human colon and rectal cancer
CPTAC, T. N., Zhang, B., Wang, J., Wang, X., Zhu, J., Liu, Q., Shi, Z., Chambers, M. C., Zimmerman, L. J., Shaddox, K. F., et al. (2014) · Nature · doi:10.1038/nature13438 · Cited by 1,462
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Zhou, Z., He, H., Wang, K., Shi, X., Wang, Y., Su, Y., Wang, Y., Li, D., Liu, W., Zhang, Y., et al. (2020) · Science · doi:10.1126/science.aaz7548 · Cited by 1,317
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Mapping intact protein isoforms in discovery mode using top-down proteomics
Tran, J. C., Zamdborg, L., Ahlf, D. R., Lee, J. E., Catherman, A. D., Durbin, K. R., Tipton, J. D., Vellaichamy, A., Kellie, J. F., Li, M., et al. (2011) · Nature · doi:10.1038/nature10575 · Cited by 665 · cited 5×
“The previous literature studies typically use one LC-MS/MS or CZE-MS/ MS – based approach ( 18 – 23 ).”
Influential
Research works printed but not linked: 45
- 10.1038/s41577-021-00534-x · DOI · Paper page
- 10.1007/s00216-016-0125-5 · DOI
- 10.18632/oncotarget.20345 · DOI
- 10.1371/journal.pone.0188697 · DOI
- 10.1074/mcp.M111.009712 · DOI · Paper page
- 10.1021/pr2005617 · DOI
- 10.1073/pnas.1716122115 · DOI · Paper page
- 10.1021/acs.jproteome.0c00226 · DOI
- E. N. McCool, S. Liangliang,Comparing nanoflow reversed-phase liquid chromatography-tandem mass spectrometry and capillary zone electrophoresis-tandem mass spectrometry for top-down proteomics. Se Pu37,878–886 (2019).
- 10.1021/acs.jproteome.9b00545 · DOI
- 10.1002/mas.21714 · DOI
- 10.1186/s13578-019-0361-4 · DOI · Paper page
- 10.18632/oncotarget.1548 · DOI · Paper page
- 10.1016/j.cub.2022.04.088 · DOI
- 10.1309/AJCPW1W8GJBQGCNI · DOI
- 10.4161/cc.9.20.13630 · DOI
- 10.4149/neo_2017_518 · DOI
- 10.1038/s12276-018-0116-z · DOI · Paper page
- 10.1016/S1367-5931(02)00009-1 · DOI · Paper page
- 10.1210/er.2004-0008 · DOI · Paper page
- 10.1021/pr300630k · DOI · Paper page
- 10.1021/acs.jproteome.9b00339 · DOI
- 10.1021/acs.jproteome.9b00840 · DOI
- 10.1074/mcp.M114.047480 · DOI · Paper page
- 10.1021/acs.jproteome.0c00369 · DOI
- 10.1096/fj.09-146001 · DOI
- 10.18632/oncotarget.20580 · DOI
- 10.17219/acem/64877 · doi:10.17219/acem/64877
- 10.1038/nmeth.3901 · DOI · Paper page
- 10.1016/j.bbagrm.2009.11.016 · DOI · Paper page
- 10.3892/or.2017.5457 · doi:10.3892/or.2017.5457
- 10.3892/or.2013.2866 · doi:10.3892/or.2013.2866
- 10.1136/gutjnl-2020-320652 · DOI
- 10.1038/nrc1885 · DOI · Paper page
- B. Sun, X. Gu, Z. Chen, J. Xiang,MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor. Am. J. Cancer Res.5,3635–3644 (2015).
- 10.3390/ijms21030765 · DOI
- 10.1016/j.bbrc.2020.05.062 · doi:10.1016/j.bbrc.2020.05.062
- 10.4161/cbt.2.4.451 · DOI · Paper page
- 10.1093/nar/gky1106 · DOI · Paper page
- 10.1021/ja011335z · DOI · Paper page
- 10.1021/acs.analchem.5b00881 · DOI · Paper page
- 10.1002/rcm.4672 · DOI · Paper page
- 10.1016/j.talanta.2015.06.003 · DOI · Paper page
- 10.1101/gr.107524.110 · DOI · Paper page
- 10.1093/nar/gkq603 · DOI · Paper page
Cited by
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Self-citationTop-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression
Forte, E., Sanders, J. M., Pla, I., Kanchustambham, V. L., Hollas, M. A. R., Huang, C.-F., Sanchez, A., Peterson, K. N., Melani, R. D., Huang, A., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100876 · Cited by 22
AI-Assisted Native Proteomics: Delineating Ribosomal Protein Conformations Pre- and Post-Assembly
Zhang, W., Sun, C., Xu, Z., & Xu, W. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c01431 · Cited by 3
Metadata
- Authors
- McCool, E. N., Xu, T., Chen, W., Beller, N. C., Nolan, S. M., Hummon, A. B., Liu, X., & Sun, L.
- Venue
- Science Advances
- Published
- 2022-12-23
- Volume
- 8
- Issue
- 51
- Pages
- eabq6348-eabq6348
- ISSN
- 2375-2548 (ISSN-L)
- OpenAlex
- W4313486347
- Cited by
- 88
- References
- 30
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep top-down proteomics revealed significant proteoform-level differences between metastatic and nonmetastatic colorectal cancer cells. https://app.cochat.ai/papers/10.1126/sciadv.abq6348
- The paper
- McCool, E. N., Xu, T., Chen, W., Beller, N. C., Nolan, S. M., Hummon, A. B., Liu, X., & Sun, L. (2022). Deep top-down proteomics revealed significant proteoform-level differences between metastatic and nonmetastatic colorectal cancer cells. Science Advances. https://doi.org/10.1126/sciadv.abq6348
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.